During the past decade, Elisabeth Krankenhaus conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Elisabeth Krankenhaus" #1 sponsor was "Biotronik SE & Co. KG" with 1 trials, followed by "Cardiac Dimensions Pty Ltd" with 1 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Stiftung Institut fuer Herzinfarktforschung" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Elisabeth Krankenhaus" #1 collaborator was "German CLL Study Group" with 1 trials as a collaborator, "Menzies Institute for Medical Research" with 1 trials as a collaborator, "Pronova BioPharma" with 1 trials as a collaborator and "Trommsdorff GmbH & Co. KG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Elisabeth Krankenhaus" are "Acute Myeloid Leukemia (AML)" (1 trials), "Cardiac Pacing, Artificial" (1 trials), "Heart Failure" (1 trials), "Leukemia" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Elisabeth Krankenhaus" in a lesser frequency.

Most popular intervention types in "Elisabeth Krankenhaus" are "Drug" (4 trials), "Device" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "CARILLON Mitral Contour System" (1 trials), "Cyclophosphamide" (1 trials), "Cytarabine" (1 trials), "Dasatinib" (1 trials) and "Fludarabine Phosphate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Elisabeth Krankenhaus" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Elisabeth Krankenhaus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Elisabeth Krankenhaus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Elisabeth Krankenhaus, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".